163 related articles for article (PubMed ID: 9684926)
1. The role of recombinant erythropoietin for the treatment of anemia in multiple myeloma.
Musto P
Leuk Lymphoma; 1998 Apr; 29(3-4):283-91. PubMed ID: 9684926
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
[TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis and erythropoietin in multiple myeloma.
Beguin Y
Leuk Lymphoma; 1995 Aug; 18(5-6):413-21. PubMed ID: 8528047
[TBL] [Abstract][Full Text] [Related]
6. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma.
Silvestris F; Romito A; Fanelli P; Vacca A; Dammacco F
Ann Hematol; 1995 Jun; 70(6):313-8. PubMed ID: 7632811
[TBL] [Abstract][Full Text] [Related]
8. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.
Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E
Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947
[TBL] [Abstract][Full Text] [Related]
10. Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis.
Musto P; Falcone A; D'Arena G; Scalzulli PR; Matera R; Minervini MM; Lombardi GF; Modoni S; Longo A; Carotenuto M
Eur J Haematol; 1997 May; 58(5):314-9. PubMed ID: 9222286
[TBL] [Abstract][Full Text] [Related]
11. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
Kostova G; Siljanovski N
Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
[TBL] [Abstract][Full Text] [Related]
12. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure.
Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC
Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197
[TBL] [Abstract][Full Text] [Related]
13. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
[TBL] [Abstract][Full Text] [Related]
15. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.
Oster W; Herrmann F; Gamm H; Zeile G; Lindemann A; Müller G; Brune T; Kraemer HP; Mertelsmann R
J Clin Oncol; 1990 Jun; 8(6):956-62. PubMed ID: 2189957
[TBL] [Abstract][Full Text] [Related]
17. [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].
Ciepłuch H; Zaucha JM; Lysiak-Szydłowska W; Hellmann A
Pol Arch Med Wewn; 1995 Aug; 94(2):153-8. PubMed ID: 8596750
[TBL] [Abstract][Full Text] [Related]
18. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
[No Abstract] [Full Text] [Related]
19. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
20. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]